Achieve Life Sciences (ACHV)President & CMO sold ~$77K

~$77K

Approx. value · 28K sh @ $2.77

116K

Holds after · shares reported

Traded

Sep 4, 2025

Filed

Sep 8, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Sep 4, 2025 · this disclosureInsiderOfficer sold ~$77K of ACHV shares in the open market

What came next

1. Sep 4, 2025Insider · 3 peopleInsiders: 3 sales (~$484K)
2. Sep 5, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On September 5, 2025, Dr. Cindy Jacobs informed the board of directors (the “Board”) of Achieve Life Sciences, Inc. (the “Company”), that she has elected to resign from her role as the Company’s Chief Medical Officer and President, effective as of October 6, 2025.”
3. Sep 18, 2025Insider · 2 peopleInsiders: 2 sales (~$524K)
4. Oct 6, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On September 11, 2025, Achieve Life Sciences, Inc. (the “Company”) previously announced that Dr. Cindy Jacobs had informed the Company’s board of directors that she had elected to resign from her role as the Company’s Chief Medical Officer and President, effective as of October 6, 2025 (the “Separation Date”).”
5. Nov 6, 2025Company filing · Form 8-K · ResultsReported its results

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Achieve Life Sciences

For Achieve Life Sciences, OQRO holds 3 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ACHV page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Achieve Life Sciences

• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 4Sep 22, 2025
• SEC Form 4Sep 22, 2025
• SEC Form 4Sep 8, 2025

Everything OQRO holds on this company is on its ACHV page.